PD
ENTA icon

Point72 (DIFC)’s Enanta Pharmaceuticals ENTA Stock Holding History

Point72 (DIFC)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.85K Buy
+739
New +$5.91K ﹤0.01% 957
2024
Q4 		– Sell
-401
Closed -$4.15K – 1619
2024
Q3 		$4.15K Buy
+401
New +$5.24K ﹤0.01% 1308

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 (DIFC)'s ENTA Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2025: 739 shares worth $8.85K. The stake represents ﹤0.01% of the portfolio and ranks #957 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in ENTA as recently as Q3 2024.

Point72 (DIFC) first reported a position in ENTA in Q3 2024 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold ENTA as of Q3 2025.

  • Point72 (DIFC) held 739 shares of Enanta Pharmaceuticals worth $8.85K as of Q3 2025.
  • Enanta Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • Enanta Pharmaceuticals made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #957 holding.
  • Point72 (DIFC) first reported a position in Enanta Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.